Autophagy is abnormally high in cell lines in culture derived from ductal pancreatic adenocarcinoma (PDAC)

被引：0
|
作者：
Larsen, Christian-Jacques
机构：
来源：
BULLETIN DU CANCER | 2011年 / 98卷 / 07期
关键词：
CANCER;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：719 / 722
页数：4
相关论文
共 50 条
  • [11] Impact of KRAS alterations in pancreatic ductal adenocarcinoma (PDAC).
    Mehdi, Maahum
    Kamgar, Mandana
    George, Ben
    Szabo, Aniko
    Annunzio, Kaitlin
    Taylor, Bradley W.
    Shreenivas, Aditya Varnam
    Chakrabarti, Sakti
    Thomas, James P.
    Tsai, Susan
    Christians, Kathleen K.
    Evans, Douglas B.
    Clarke, Callisia
    Hall, William Adrian
    Erickson, Beth
    Ahmed, Gulrayz
    Thapa, Bicky
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [12] Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
    Michalak, Natalia
    Malecka-Wojciesko, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [13] Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC).
    Krantz, Benjamin A.
    Tsui, Dana
    Lowery, Maeve Aine
    Capanu, Marinela
    Yu, Kenneth H.
    Kelsen, David Paul
    Gedvilaite, Erika
    Zhang, Liguo
    Selcuklu, S. Duygu
    You, Daoqi
    Pernicka, Jennifer S. Golia
    Do, Richard K. G.
    Iacobuzio-Donahue, Christine A.
    O'Reilly, Eileen Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [14] Prognostic Metabolic Signatures in Pancreatic Ductal Adenocarcinoma (PDAC).
    Karasinska, Joanna
    Kalloger, Steve
    Wong, Hui-Li
    Renouf, Daniel
    Schaeffer, David
    MODERN PATHOLOGY, 2018, 31 : 680 - 680
  • [15] pH Regulatory Transporters in Pancreatic Ductal Adenocarcinoma (PDAC)
    Kong, Su Chii
    Christensen, Sandra
    Hoffmann, Else Kay
    Novak, Ivana
    Pedersen, Stine Falsig
    FASEB JOURNAL, 2013, 27
  • [16] Autophagy in the Genesis of Pancreatic Ductal Adenocarcinoma
    Rosenfeldt, M. T.
    PATHOLOGE, 2017, 38 : S172 - S174
  • [17] Characterization of primary and metastatic pancreatic tumors in pancreatic ductal adenocarcinoma (PDAC)
    Martinez-Muniz, Andres E.
    Sivanand, Sharanya
    Vander Heiden, Matthew
    CANCER RESEARCH, 2019, 79 (13)
  • [18] The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment
    Papadakos, Stavros P. P.
    Dedes, Nikolaos
    Gkolemi, Nikolina
    Machairas, Nikolaos
    Theocharis, Stamatios
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [19] Neurotensin is a versatile modulator of in vitro human Pancreatic Ductal Adenocarcinoma Cell (PDAC) migration
    Mijatovic, Tatjana
    Gailly, Philippe
    Mathieu, Veronique
    De Neve, Nancy
    Yeaton, Paul
    Kiss, Robert
    Decaestecker, Christine
    CELLULAR ONCOLOGY, 2007, 29 (04) : 315 - 326
  • [20] The Effects of Treatment on Peripheral Blood Immune Cell Profile in Pancreatic Ductal Adenocarcinoma (PDAC)
    Tulyte, Skaiste
    Characiejus, Dainius
    Matuzeviciene, Reda
    Janiulioniene, Ausra
    Radzevicius, Mantas
    Zvirblis, Tadas
    Sileikis, Audrius
    ANTICANCER RESEARCH, 2022, 42 (06) : 3067 - 3073
12345